BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial
"These first trial results show that the vaccine yields immune activity and causes a strong immune response," said BioNTech's co-founder and Chief Executive Officer Ugur Sahin.
Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration(photo credit: REUTERS/ DADO RUVIC)ByREUTERS
